Drug Safety Bill Authorizes Fines On Industry, But Does Not Include User Fees

The Center for Postmarket Drug Evaluation & Research proposed in legislation from Sens. Grassley and Dodd would be funded by appropriations, not user fees

More from Archive

More from Pink Sheet